Access to anti-retroviral drugs, male in Gambia
Gambia: Access to anti-retroviral drugs, male was 27.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Gambia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Gambia recorded 27.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 12.5% on the previous year and up 170.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Gambia peaked at 27.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Gambia 136th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Gambia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 2.0% | +0.0% |
| 2007 | 2.0% | +0.0% |
| 2008 | 4.0% | +100.0% |
| 2009 | 4.0% | +0.0% |
| 2010 | 8.0% | +100.0% |
| 2011 | 9.0% | +12.5% |
| 2012 | 11.0% | +22.2% |
| 2013 | 11.0% | +0.0% |
| 2014 | 10.0% | -9.1% |
| 2015 | 12.0% | +20.0% |
| 2016 | 14.0% | +16.7% |
| 2017 | 14.0% | +0.0% |
| 2018 | 16.0% | +14.3% |
| 2019 | 17.0% | +6.2% |
| 2020 | 18.0% | +5.9% |
| 2021 | 19.0% | +5.6% |
| 2022 | 23.0% | +21.1% |
| 2023 | 24.0% | +4.3% |
| 2024 | 27.0% | +12.5% |
Gambia compared with similar countries
- Gambia's 27.0% is below the median for low income countries, which is 65.5%, 41% of the median. (24 countries reporting)
- Gambia's 27.0% is below the median for Sub-Saharan Africa, which is 76.5%, 35% of the median. (44 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male in Gambia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2008 | +100.0% | 2.0% | 4.0% |
| 2010 | +100.0% | 4.0% | 8.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.4% | 0.0% | 4.0% | 10 |
| 2010s | 12.2% | 8.0% | 17.0% | 10 |
| 2020s | 22.2% | 18.0% | 27.0% | 5 |
Countries ranked near Gambia
More gender data for Gambia
- Child population (UN estimates and projections) 1,149 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.4019 % change on previous year (2030)
- Population 1,981 (2030)
- Working-age population (UN estimates and projections) 1,981 (2030)
- Population (UN estimates and projections), annual growth rate 2.94 % change on previous year (2030)
- Age population, age 00, female, interpolated 39,680 (2025)
- Age population, age 00, male, interpolated 40,675 (2025)
- Age population, age 01, female, interpolated 39,327 (2025)
- Age population, age 01, male, interpolated 40,247 (2025)
- Age population, age 02, female, interpolated 38,827 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Gambia?
- Access to anti-retroviral drugs, male in Gambia was 27.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Gambia?
- The highest recorded value was 27.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Gambia?
- The lowest recorded value was 0.0% in 2000.
- How does Gambia rank for access to anti-retroviral drugs, male?
- Gambia ranks 136th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Gambia?
- Over the last ten years it is up 170.0%. The long-run trend across the full record is volatile.
- Where does this Gambia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.